Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : OSI Pharmaceuticals (OSIP) - formerly Oncogene -- Ignore unavailable to you. Want to Upgrade?

To: mac who wrote (13)	6/15/1998 2:57:00 AM
From: 777 Captain	Read Replies (1) \| Respond to of 447

mac: I wish I knew why OSIP has done basically nothing for some time now. I'm standing aside, although I did notice what appeared to be institutional buying in OSIP earlier this year. I keep hearing good news, and yet I don't see the stock move - which indicates to me that the market knows something that I don't. Over time I've learned (painfully) that I'm not as smart as the market. In the case of most of the pharmaceuticals that I've previously owned (PRX comes to mind as a recent sale after buying in at about 2.00/share,) the company has to do something significant e.g., reach a milestone before the stock actually moves. In the case of PRX, it was a marketing agreement. I'm still watching the volume/accumulation at OSIP, and will continue to do so. Regards.